Summary
The effect of acute i.v. administration of 2.5 mg metoclopramide (MCP), an antidopaminergic agent with low serotoninergic activity, on blood insulin and glucose concentrations was studied in 9 healthy men. MCP was able to significantly decrease basal serum insulin levels (from 6.8 ± 1.1 to 4.3 ± 0.7 µU/ml in 120 min; p<0.025) with a parallel elevation in blood glucose (from 72.5 ± 1.1 to 82.6 ± 2.5 mg/dl in 120 min; p<0.01). These findings, which were not observed after placebo, and appeared not to be explained by the spontaneous occurrence of physiological oscillations of insulin and glucose plasma levels, are consistent with similar effects observed after administration of other antidopaminergic agents and with the stimulatory activity on insulin and glucagon release described during dopamine infusion in man.
This is a preview of subscription content, log in via an institution to check access.
References
Aleyassine H., Lee S. H.: Inhibition of insulin release by substrates of inhibitors and monoamine oxidase — Amer. J. Physiol.222, 565–569, 1972.
Caviezel F., Spotti D., Rilli Spinaci R.: The stimulatory activity of dopamine on insulin and glucagon secretion in man — Diabetologia23, 295, 1982; Abstract
Caviezel F., Spotti D., Cattaneo A. G., Ubaldi E., Santorelli G., Pozza G.: Studi sul controllo dopaminergico della secrezione insulinica nell’uomo — J. endocrinol. Invest.4 (Suppl. 1), 309–311, 1981.
Cegrell L.: The occurrence of biogenic monoamines in the mammalian endocrine pancreas — Acta physiol. scand.314 (Suppl), 1968.
Ekholm R., Ericson L. E., Lundquist I.: Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography — Diabetologia7, 339–348, 1970.
Ericson L. E., Hakanson R., Lundquist I.: Accumulation of dopamine in mouse pancreatic B-cells following injection of L-dopa. Localization to secretory granules and inhibition of insulin secretion — Diabetologia13, 117–124, 1977.
Falck B., Hellman B.: Evidence for the presence of biogenic amines in pancreatic islets — Experientia (Basel)19, 139–140, 1963.
Fang V. S., Shian L-R.: A serotoninergic mechanism of the prolactin-stimulating action of metoclopramide — Endocrinology108, 1622–1627, 1981.
Federspil G., Casara D., Pedrazzoli S., Sicolo N., Scandellari C.: In vivo studies on 5-hydroxytryptamine and insulin secretion in dogs and in man — Diabetologia4, 253–256, 1974.
George D. T., Rayfield E. J.: L-dopa induced plasma glucagon release — J. clin. Endocrinol. Metabol.39, 618–621, 1974.
Hansen B. C., Jen K. C., Pek S., Wolfe R. A.: Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans — J. clin. Endocrinol. Metabol.54, 785–792, 1982.
Lang D. A., Matthews D. R., Burnett M., Ward G. M., Turner R. C.: Pulsatile, synchronous basal insulin and glucagon secretion in man — Diabetes31, 22–26, 1982.
Lang D. A., Matthews D. R., Petro J., Turner R. C.: Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings — New Engl. J. Med.301, 1023–1027, 1979.
Leblanc H., Lachelin G. C. L., Abu-Fadil S., Yen S. S. C.: The effect of dopamine infusion on insulin and glucagon secretion in man — J. clin. Endocrinol. Metabol.44, 196–198, 1977.
Lechin F., Coll-Garcia E., van der Dijs B., Bentolila A., Pena F., Rivas C.: The effect of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs — Experientia (Basel)35, 886–887, 1979.
Lorenzi M., Karam J. E., Tsalikian E., Bohannon N. V., Gerich J. E., Forsham P. H.: Dopamine during α- or β-adrenergic blockade in man. Hormonal, metabolic and cardiovascular effects — J. clin. Invest.63, 310–317, 1979.
Lundquist I.: Insulin secretion. Its regulation by monoamines and acid amyloglucosidase — Acta physiol. scand.372 (Suppl.), 1–47, 1971.
Peringer E., Jenner P., Donaldson I. M., Marsden C. D., Miller R.: Metoclopramide and dopamine receptor blockade — Neuropharmacology15, 463–469, 1976.
Pezzarossa A., Vescovi P. P., Cervigni C., Angelini O., Cimicchi M. C., Capretti L., Campana G., Butturini U.: Effect of domperidone on the release of insulin after intravenous glucose load in man — J. endocrinol. Invest.9, 383–388, 1986.
Pontiroli A. E., Micossi P., Foà P. P.: Effects of serotonin, of its biosynthetic precursors and of antiserotonin agent meterogoline on the release of glucagon and insulin from rat pancreas — Hormone metabol. Res.10, 200–203, 1978.
Quickel K. E. Jr., Feldman J. M., Lebovitz H. E.: Inhibition of insulin secretion by serotonin and dopamine: species variation — Endocrinology89, 1295–1302, 1971.
Rayfield E. J., George D. T., Eichner H. L., Hsu T. H.: L-dopa stimulation of glucagon secretion in man — New Engl. J. Med.239, 589–591, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morricone, L., Murari, M., Bombonato, M. et al. Effect of acute administration of metoclopramide on insulin secretion in man. Acta diabet. lat 27, 53–57 (1990). https://doi.org/10.1007/BF02624722
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624722